Form 4: NextCure Insider Buys Shares
Insider Transaction (Form 4)
ADAR1 Capital Management, LLC and 1 other reported changes in beneficial ownership of NextCure, Inc. common stock on July 30, 2026.
Summary
- Open-market purchase: acquired 50,000 Common Stock at $4.97 ($248,615) on July 30, 2026; holds 443,266 after (Indirect).
- Open-market purchase: acquired 20,000 Common Stock at $5.00 ($100,000) on July 30, 2026; holds 463,266 after (Indirect).
- Open-market purchase: acquired 20,000 Common Stock at $5.00 ($100,000) on July 30, 2026; holds 483,266 after (Indirect).
- Open-market purchase: acquired 25,000 Common Stock at $4.81 ($120,338) on July 30, 2026; holds 508,266 after (Indirect).
- Open-market purchase: acquired 100,000 Common Stock at $4.90 ($490,000) on July 30, 2026; holds 608,266 after (Indirect).
- Open-market purchase: acquired 77,850 Common Stock at $4.96 ($385,793) on July 30, 2026; holds 686,116 after (Indirect).
- Open-market purchase: acquired 3,300 Common Stock at $4.98 ($16,420) on July 31, 2026; holds 689,416 after (Indirect).
- Open-market purchase: acquired 25,000 Common Stock at $4.98 ($124,540) on July 31, 2026; holds 714,416 after (Indirect).
- Open-market purchase: acquired 8,003 Common Stock at $4.80 ($38,414) on July 31, 2026; holds 722,419 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,624,120, committing personal capital to the stock.
Insider Transactions
ADAR1 Capital Management, LLC — 10% owner
Daniel Schneeberger — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market purchase | Common Stock | 50,000 | $5 | $248.6K | 443,266 |
| 2026-07-30 | Open-market purchase | Common Stock | 20,000 | $5 | $100.0K | 463,266 |
| 2026-07-30 | Open-market purchase | Common Stock | 20,000 | $5 | $100.0K | 483,266 |
| 2026-07-30 | Open-market purchase | Common Stock | 25,000 | $5 | $120.3K | 508,266 |
| 2026-07-30 | Open-market purchase | Common Stock | 100,000 | $5 | $490.0K | 608,266 |
| 2026-07-30 | Open-market purchase | Common Stock | 77,850 | $5 | $385.8K | 686,116 |
| 2026-07-31 | Open-market purchase | Common Stock | 3,300 | $5 | $16.4K | 689,416 |
| 2026-07-31 | Open-market purchase | Common Stock | 25,000 | $5 | $124.5K | 714,416 |
| 2026-07-31 | Open-market purchase | Common Stock | 8,003 | $5 | $38.4K | 722,419 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market purchase (50,000 shares) |
| 2026-07-30 | Open-market purchase (20,000 shares) |
| 2026-07-30 | Open-market purchase (20,000 shares) |
| 2026-07-30 | Open-market purchase (25,000 shares) |
| 2026-07-30 | Open-market purchase (100,000 shares) |
| 2026-07-30 | Open-market purchase (77,850 shares) |
| 2026-07-31 | Open-market purchase (3,300 shares) |
| 2026-07-31 | Open-market purchase (25,000 shares) |
| 2026-07-31 | Open-market purchase (8,003 shares) |
Keywords
insider transaction, Form 4, NXTC, NextCure, Inc., bullish, ADAR1 Capital Management, LLC, Daniel Schneeberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.